“WI continues to grow and we are excited to be exhibiting for a second year at this important meeting for clinical development professionals,” says Ms. Whitsell. “We know how industry members use DIA as a means for professional development and we are thrilled to be able to share our expertise with this community.”WI members will also be available to discuss the changing regulations regarding electronic technical document (eCTD) submissions, including the 2009 FDA guidance for integrated summaries of effectiveness and safety location in the eCTD and CMC submissions in the eCTD format. DIA is a nonprofit, global, professional association of nearly 18,000 members who work in every facet of the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products. DIA is committed to the broad dissemination of information among its members, with continuously improved professional practice as the goal. DIA serves our members in a neutral, global environment that operates independent of the influence of any one organization or authority.
Whitsell Innovations, Inc. to Exhibit at Drug Information Association DIA 2012 48th Annual Meeting
Whitsell Innovations (WI), Inc., a full-service medical and scientific writing company headquartered in Chapel Hill, NC, will be one of the exhibitors at Drug Information Association (DIA) 2012 48th Annual Meeting this year. The DIA meeting is scheduled to be held from June 24 through June 28, 2012 in Philadelphia, PA. President and founder of WI Robin Whitsell, Medical Writer and Consultant Ann Winter-Vann, PhD, Technical Writer and CMC Consultant Mary Ellis Bogden, and Business Development Associate Natalie Becker will all be in attendance at the Whitsell Innovations, Inc. Booth # 1740. The team will be discussing the experience of WI with medical writing and outsourcing best practices for pharmaceutical, biotech and device companies including the documentation required for submissions to the Food and Drug Administration (FDA) and international regulatory bodies during the pre-clinical and clinical development process. They will also address how industry clients use medical writers to share clinical data in manuscripts, training materials, and presentations.